「Formula」を含む例文一覧(20395)

＜前へ 1 2 .... 9 10 11 12 13 14 15 16 17 .... 407 408 次へ＞
  • This organometallic complex is expressed by general formula (1).
    一般式（１）で表される有機金属錯体。 - 特許庁
  • The dye compound is represented by the general formula (1).
    下記一般式（１）で表される色素化合物。 - 特許庁
  • The new polyhydric alcohol is represented by formula [1].
    式［１］で表される新規な多価アルコールとする。 - 特許庁
  • The transition metal complex is represented by the general formula (1).
    一般式（１） で示される遷移金属錯体。 - 特許庁
  • The compound is represented by general formula (I).
    下記一般式（Ｉ）で表される化合物である。 - 特許庁
  • In formula (I), X^1 represents -O-CO-.
    式（Ｉ）中、Ｘ^１は−Ｏ−ＣＯ−を表す。 - 特許庁
  • There is provided folate-fluorescein isothiocyanate represented by formula.
    下図に示される葉酸塩ーフルオレセインイソチオシアネート。 - 特許庁
  • A computing unit 18 performs operation according to a mathematical formula shown by the post-operation mathematical formula information, and outputs an operation result when the post-operation mathematical formula generation unit 17 generates the post-operation mathematical formula information.
    演算部１８は、操作後数式生成部１７が操作後数式情報を生成したときに、操作後数式情報が表す数式に基づいて演算を行い演算結果を出力する。 - 特許庁
  • The iodine compound is represented by general formula (I).
    下記一般式（Ｉ）で表されるヨウ素化合物。 - 特許庁
  • The metal compound is expressed by general formula (1).
    下記一般式（１）で表される金属化合物。 - 特許庁
  • The pigment compound is represented by general formula (1).
    下記一般式（１）で表される色素化合物。 - 特許庁
  • The invention concerns electrochromic compounds of general formula V.
    一般式Ｖのエレクトロクロミック化合物に関する。 - 特許庁
  • This ink set comprises magenta ink compositions which contain as colorants a compound of general formula (III) e.g. formula (M-1) and general formula (IV) e.g. formula (LM-4).
    マゼンタインク組成物を含んでなるインクセットであって、該マゼンタインク組成物が着色剤として一般式ＩＩＩ、例えば式Ｍ−１及び（ＩＶ）、例えば式ＬＭ−４の化合物を含んでなるインクセット。 - 特許庁
  • GEL-LIKE FORMULA FEED AND METHOD FOR FEEDING THE SAME
    ゲル状配合飼料及びその給与方法 - 特許庁
  • The salt is characterized in that it is shown by formula (I).
    式（Ｉ）で示されることを特徴とする塩。 - 特許庁
  • The aromatic diamine compound is represented by chemical formula 1.
    次式で表される芳香族ジアミン化合物。 - 特許庁
  • General Formula (A) (wherein R^1 represents H or CH_3).
    （式中Ｒ^１はＨ又はＣＨ_３を表す） - 特許庁
  • This transition metal complex is expressed by formula (1).
    一般式（１）で表される遷移金属錯体。 - 特許庁
  • In the formula (1), m and n are each an integer of 2 or more.
    （式（１）中のｍ、ｎは２以上の整数） - 特許庁
  • The GABA analog prodrug such as to be represented by general formula (VIII) is provided.
    一般式(VIII)のようなGABA類似体のプロドラッグ。 - 特許庁
  • In the formula (1), R is H or CH_2OCOCH_3.
    Ｒは、ＨまたはＣＨ_２ＯＣＯＣＨ_３である。 - 特許庁
  • The cationic compound is represented by formula (I).
    下記一般式（Ｉ）で表される陽イオン化合物。 - 特許庁
  • The component (B) is a compound represented by general formula (4) R^3-CH_2COOH (4).
    Ｒ^３−ＣＨ_2ＣＯＯＨ 一般式 (４) - 特許庁
  • To provide a compound of the formula (II) or (III), useful as a photopolymerization initiator, to provide a compound of the formula (I), used as a raw material for the compound of the formula (II) or (III), and to provide a method for producing the compound of the formula (I), (II) or (III).
    光重合開始剤として有用な式ＩＩ、ＩＩＩの化合物及びその原料である式Ｉの化合物、さらに式ＩＩ、ＩＩＩの化合物を製造する方法の提供。 - 特許庁
  • In formula (4), Ar represents an aromatic group.
    式（４）において、Ａｒは芳香族基を表す。 - 特許庁
  • This invention relates to a heterocyclic compound that has the following formula (1).
    式(1)を有する縮合複素環式化合物。 - 特許庁
  • A new rapamycin analog is represented by the formula of the figure.
    下記式で示される新規ラパマイシン類似体。 - 特許庁
  • A transition metal complex expressed by general formula (I) is disclosed.
    一般式（Ｉ）で示される遷移金属錯体。 - 特許庁
  • The metallocene compound is represented by general formula (1).
    下記一般式（１）で表されるメタロセン化合物。 - 特許庁
  • The compound of formula I can be obtained by condensing a compound of formula II with a halogen compound of formula III in a basic medium and condensing the obtained compound with a mono-substituted hydrazine of formula IV in the presence of a coupling agent.
    Ｒ−ＮＨ−Ａ−ＣＯ−ＮＨ−ＮＨ−（Ｗ)_n−Ｚ （Ｉ） 一般式Ｉの化合物の具体例にはベンジルＮ−［１−ベンジル−２−オキソ−２−（２−フェニルヒドラジノ）エチル］カルバメートがある。 - 特許庁
  • The organic metal complex compound is expressed by general formula I.
    一般式１の有機金属錯体化合物。 - 特許庁
  • Disclosed is a novel bisphenol monoester compound represented by formula (1).
    式（１）で表されるビスフェノールモノエステル化合物。 - 特許庁
  • The triazole derivative is expressed by general formula (G3).
    一般式（Ｇ３）で表されるトリアゾール誘導体。 - 特許庁
  • The iron-salen complex is represented by general formula (I).
    下記一般式（Ｉ）で示される鉄サレン錯体。 - 特許庁
  • The norbornene derivative is represented by general formula (I).
    一般式（Ｉ）： で表わされるノルボルネン誘導体。 - 特許庁
  • The sulfenamide compound is represented by general formula (A).
    一般式（Ａ）で表されるスルフェンアミド化合物。 - 特許庁
  • The substituted chalcogeno-acene compound is represented by formula (1).
    式（１）で表される置換カルコゲノアセン化合物。 - 特許庁
  • Formula (1): A<520 nm, (2) |H-A|>15 nm.
    式（１） Ａ＜５２０ｎｍ 式（２） ｜Ｈ−Ａ｜＞１５ｎｍ - 特許庁
  • In the formula 4, R denotes an alkyl group.
    但し、［化４］において、Ｒはアルキル基を表わす。 - 特許庁
  • The fluorine containing compound is represented by the formula (1).
    下記式（１）で表されるフッ素含有化合物。 - 特許庁
  • The fluororesin is represented by the following general formula (1).
    フッ素樹脂は下記一般式（１）で表わされる。 - 特許庁
  • The diamine compound is expressed by general formula (1).
    下記一般式（１）で表されるジアミン化合物。 - 特許庁
  • The adamantane compound is represented by general formula (1).
    下記一般式（１）で示されるアダマンタン化合物。 - 特許庁
  • HS-R1 (1) In formula (I), R1 is a 1-10C alkylene group.
    （式中、Ｒ_1はＣ_1〜Ｃ_10のアルキレン基を表す。） - 特許庁
  • This polymerizable compound represented by general formula (1).
    一般式（１）で表される重合性化合物。 - 特許庁
  • The lactone derivative is represented by structural formula (I).
    下記構造式（Ｉ）で示されるラクトン誘導体。 - 特許庁
  • The coumarin compound is represented by general formula (1).
    下記一般式（１）で表わされるクマリン化合物。 - 特許庁
  • The novel flavan compound is represented by the following formula (1).
    下記式（１）で表される新規フラバン化合物。 - 特許庁
  • The subject cinnamoyl compound is expressed by formula (I).
    本発明は、式（I）で示されるシンナモイル化合物。 - 特許庁
  • The quinoxaline derivative represented by general formula (1) is provided.
    一般式（１）で表されるキノキサリン誘導体。 - 特許庁
＜前へ 1 2 .... 9 10 11 12 13 14 15 16 17 .... 407 408 次へ＞

例文データの著作権について

  • 特許庁
    Copyright © Japan Patent office. All Rights Reserved.